Lenalidomide: A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma

Author： Scott Lesley J.   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.5, 2011-03, pp. : 625-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegylated Liposomal Doxorubicin: A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma

By Plosker Greg L.  

Drugs, Vol. 68, Iss. 17, 2008-01 ,pp. : 2535-2551

Adis International

Access to resources Recommend Favorite

Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma

By McCormack Paul L.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 2023-2032

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

By Hoy Sheridan M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1929-1950

Adis International

Access to resources Recommend Favorite

New developments in the management and treatment of newly diagnosed and relapsed/refractory multiple myeloma patients

By van de Donk Niels WCJ   Lokhorst Henk M  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1569-1573

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib: A Review of its Use in Patients with Multiple Myeloma

By Curran Monique P.   McKeage Kate  

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 859-888

Adis International

Access to resources Recommend Favorite